Inventor · disambiguated record
Christiane Jaeger
Also filed as: JAEGER CHRISTIANE
3 granted patents·15 pending applications·16 citations·filing 2010–2021
62Inventor score
Top patents by PatentIndex Score
18 records- 0194US9914776B2Bispecific T cell activating antigen binding moleculesHOFFMANN LA ROCHE·Filed 2015·Granted Mar 13, 2018·16 cites·42 claims
- 0278US2021253704A1Bispecific t cell activating antigen binding moleculesROCHE GLYCART AG·Filed 2021·Application pending·0 cites
- 0375US2020385470A1Bispecific t cell activating antigen binding moleculesROCHE GLYCART AG·Filed 2020·Application pending·0 cites
- 0470US2019177413A1Bispecific t cell activating antigen binding moleculesROCHE GLYCART AG·Filed 2019·Application pending·0 cites
- 0569US2018312589A1Bispecific t cell activating antigen binding moleculesROCHE GLYCART AG·Filed 2018·Application pending·0 cites
- 0661US10352943B2A-fucosylation detection in antibodiesROCHE GLYCART AG·Filed 2016·Granted Jul 16, 2019·0 cites·10 claims
- 0760US2014302544A1A-fucosylation detection in antibodiesROCHE GLYCART AG·Filed 2014·Application pending·0 cites
- 0857US9994610B2Separation method for fucosylated antibodiesROCHE GLYCART AG·Filed 2012·Granted Jun 12, 2018·0 cites·21 claims
- 0957US2013078249A1Bispecific t cell activating antigen binding moleculesAST OLIVER·Filed 2012·Application pending·0 cites
- 1053US2018265544A1Separation method for fucosylated antibodiesROCHE GLYCART AG·Filed 2018·Application pending·0 cites
- 1150US2012196310A1A-fucosylation detection in antibodiesJAEGER CHRISTIANE·Filed 2010·Application pending·0 cites
- 1247US2013058936A1Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of useBRUENKER PETER·Filed 2012·Application pending·0 cites
- 1346US2014242080A1Bispecific t cell activating antigen binding moleculesROCHE GLYCART AG·Filed 2014·Application pending·0 cites
- 1443US2013058937A1Bispecific antigen binding moleculesAUER JOHANNES·Filed 2012·Application pending·0 cites
- 1542US2016145354A1Bispecific t cell activating antigen binding moleculesROCHE GLYCART AG·Filed 2015·Application pending·0 cites
- 1641US2013078250A1Bispecific t cell activating antigen binding moleculesAST OLIVER·Filed 2012·Application pending·0 cites
- 1739US2013060011A1Fc-free antibodies comprising two fab fragments and methods of useBRUENKER PETER·Filed 2012·Application pending·0 cites
- 1834US2017327579A1Bispecific antibodies against cd3epsilon and bcmaENGMAB AG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →